PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|---|
Total Non-Current Liabilities | ₹2,929 Cr | ₹3,812 Cr | ₹2,903 Cr | ₹2,560 Cr |
What is the latest Total Non-Current Liabilities ratio of PIRAMAL PHARMA ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹2,929 Cr |
Mar2023 | ₹3,812 Cr |
Mar2022 | ₹2,903 Cr |
Mar2021 | ₹2,560 Cr |
How is Total Non-Current Liabilities of PIRAMAL PHARMA Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹2,929 Cr | -23.17 | |
Mar2023 | ₹3,812 Cr | 31.33 | |
Mar2022 | ₹2,903 Cr | 13.37 | |
Mar2021 | ₹2,560 Cr | - |
Compare Total Non-Current Liabilities of peers of PIRAMAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PIRAMAL PHARMA | ₹25,520.6 Cr | -4.1% | -6.9% | 22.4% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹395,254.0 Cr | -2.5% | -4.9% | 8.7% | Stock Analytics | |
DIVIS LABORATORIES | ₹172,374.0 Cr | -2.7% | -0.9% | 42.5% | Stock Analytics | |
CIPLA | ₹119,795.0 Cr | -1.5% | 0.1% | -4.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹110,698.0 Cr | -2.6% | 8.3% | 7.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹107,218.0 Cr | -2.6% | -3.7% | 11.9% | Stock Analytics |
PIRAMAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PIRAMAL PHARMA | -4.1% |
-6.9% |
22.4% |
SENSEX | -0.4% |
0.2% |
5.9% |
You may also like the below Video Courses